Hirsutism in women

American Family Physician

Volumn 85, Issue 4, 2012, Pages 373-380

  Bode, David ^a   Seehusen, Dean A ^b   Baird, Drew ^c  

^a BROOKE ARMY MEDICAL CENTER   (United States)

^b FORT BELVOIR COMMUNITY HOSPITAL   (United States)

^c CARL R DARNALL ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANDROGEN; ANDROSTANOLONE; ANDROSTENEDIONE; ARIPIPRAZOLE; BIMATOPROST; CARBAMAZEPINE; CLONAZEPAM; CYCLOSPORIN A; CYPROTERONE; DANTROLENE; DIAZOXIDE; DONEPEZIL; EFLORNITHINE; FINASTERIDE; FLUTAMIDE; GLUCOCORTICOID; GONADORELIN AGONIST; HYDROXYPROGESTERONE; KETOCONAZOLE; LEUPRORELIN; METFORMIN; ORAL CONTRACEPTIVE AGENT; PIOGLITAZONE; PRASTERONE; PREDNISONE; PROLACTIN; SPIRONOLACTONE; TESTOSTERONE; UNINDEXED DRUG;

ACNE; ACROMEGALY; ADRENAL HYPERPLASIA; ADRENAL SUPPRESSION; ANDROGEN BLOOD LEVEL; ARTICLE; ATROPHIC VAGINITIS; BONE DENSITY; BURNING SENSATION; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; CUSHING DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRY SKIN; ERYTHEMA; ESTHETIC SURGERY; GASTROINTESTINAL SYMPTOM; HIRSUTISM; HORMONE BLOOD LEVEL; HOT FLUSH; HUMAN; HYPERANDROGENISM; HYPERKALEMIA; HYPERPROLACTINEMIA; INSULIN SENSITIVITY; LIVER TOXICITY; LOW LEVEL LASER THERAPY; MENSTRUAL IRREGULARITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHYSICAL EXAMINATION; PROLACTIN BLOOD LEVEL; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; THYROID DISEASE; THYROID FUNCTION TEST; TREATMENT RESPONSE; VIRILIZATION; WEIGHT GAIN;

EID: 84857410892     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(4):1105-1120.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-2749.
3. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. J Clin Endocrinol Metab. 2005;90(8):4650-4658.
4. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21(4):363-392.
5. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815-830.
6. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-1447.
7. Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010;16(1):51-64.
8. Rosenfield RL. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc. 2005;10(3):205-208.
9. Carmina E, Rosato F, Jannì A, Rizzo M, Longo RA. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2-6.
10. Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore). 2009;88(1):32-45.
11. Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453-462.
12. Fauci AS, et al., eds. 2008. Harrison's Principles of Internal Medicine. 17th ed. New York, NY: McGraw-Hill Medical; 2008.
13. Physicians' Desk Reference Web site. http://www.pdr.net. Accessed April 13, 2011.
14. Codner E, Escobar-Morreale HF. Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus. J Clin Endocrinol Metab. 2007;92(4):1209-1216.
15. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev. 2000;21(4):347-362.
16. Reingold SB, Rosenfield RL. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol. 1987;123(2):209-212.
17. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2006;91(11):4205-4214.
18. Hunter MH, Carek PJ. Evaluation and treatment of women with hirsutism. Am Fam Physician. 2003;67(12):2565-2572.
19. Rosenfield RL. Clinical practice. Hirsutism. N Engl J Med. 2005;353(24):2578-2588.
20. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab. 2007;92(2):405-413.
21. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93(5):1553-1562.
22. Blume-Peytavi U, Atkin S, Shapiro J, et al.; Skin Academy. European Consensus on the evaluation of women presenting with excessive hair growth. Eur J Dermatol. 2009;19(6):597-602.
23. Koulouri O, Conway GS. A systematic review of commonly used medical treatments for hirsutism in women. Clin Endocrinol (Oxf). 2008;68(5):800-805.
24. Haedersdal M, Gøtzsche PC. Laser and photoepilation for unwanted hair growth. Cochrane Database Syst Rev. 2006;(4):CD004684.
25. Cosma M, Swiglo BA, Flynn DN, et al. Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008;93(4):1135-1142.
26. Radosh L. Drug treatments for polycystic ovary syndrome. Am Fam Physician. 2009;79(8):671-676.
27. Brown J, Farquhar C, Lee O, Toomath R, Jepson RG. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev. 2009;(2):CD000194.